about
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metaboli...
Read More
204.99
0.72
(0.35%)
1.2M
XNYS Volume
XNYS 09 Apr, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Astrazeneca plc is scheduled for today, for the purpose of AstraZeneca PLC Annual General Meeting for 2026
See details
Low Financial Strength
Expensive Valuation
No Score Avaliable
Astrazeneca plc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..